Global trends and projections of Parkinson's disease incidence: a 30-year analysis using GBD 2021 data.

IF 4.6 2区 医学 Q1 CLINICAL NEUROLOGY Journal of Neurology Pub Date : 2025-03-25 DOI:10.1007/s00415-025-13030-2
Libo Xu, Zhenhao Wang, Qingsong Li
{"title":"Global trends and projections of Parkinson's disease incidence: a 30-year analysis using GBD 2021 data.","authors":"Libo Xu, Zhenhao Wang, Qingsong Li","doi":"10.1007/s00415-025-13030-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Parkinson's disease (PD) is a neurodegenerative disorder marked by the progressive loss of dopaminergic neurons, leading to motor dysfunction and non-motor symptoms like cognitive decline and depression. With the aging global population, PD incidence is anticipated to rise, especially in regions with rapidly growing elderly populations. This study leverages Global Burden of Disease (GBD) 2021 data to analyze the burden of PD by region, sex, and age group, examining trends from 1992 to 2021 and projecting the future burden to 2030.</p><p><strong>Methods: </strong>Data from the GBD 2021 database for the years 1992-2021 were analyzed to assess age-standardized incidence rates (ASIR) and mortality of PD across socio-demographic index (SDI) regions, sex, and age groups. The Age-Period-Cohort (APC) model was used to explore temporal trends, while the Bayesian Age-Period-Cohort (BAPC) model projected future PD burden from 2022 to 2030.</p><p><strong>Results: </strong>From 1992 to 2021, global PD cases increased from 450,000 to 1.34 million, with crude incidence rates rising from 8.19 to 16.92 per 100,000 and ASIR from 11.54 to 15.63 per 100,000, indicating an annual net drift of 1.11% (95% CI 1.06%-1.17%), reflecting a growing burden driven by an aging population. All SDI regions saw a growth in PD burden, with the highest increases in middle- and high-middle-SDI regions, where male incidence was notably higher than female. Incidence rates escalated sharply in individuals aged 60 and older, peaking in those aged 85 and above. Projections suggest that by 2030, global PD cases will reach 1.93 million, with an ASIR of 27 per 100,000.</p><p><strong>Discussion: </strong>The findings highlight a sustained global increase in PD burden, particularly in middle- and high-income regions and among men. In low-SDI areas, PD burden may be underestimated due to limited healthcare access and diagnostic challenges. These results stress the urgent need for health policies focused on elderly populations, especially men, and call for effective prevention and intervention strategies to mitigate the future impact of PD.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"272 4","pages":"286"},"PeriodicalIF":4.6000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00415-025-13030-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Parkinson's disease (PD) is a neurodegenerative disorder marked by the progressive loss of dopaminergic neurons, leading to motor dysfunction and non-motor symptoms like cognitive decline and depression. With the aging global population, PD incidence is anticipated to rise, especially in regions with rapidly growing elderly populations. This study leverages Global Burden of Disease (GBD) 2021 data to analyze the burden of PD by region, sex, and age group, examining trends from 1992 to 2021 and projecting the future burden to 2030.

Methods: Data from the GBD 2021 database for the years 1992-2021 were analyzed to assess age-standardized incidence rates (ASIR) and mortality of PD across socio-demographic index (SDI) regions, sex, and age groups. The Age-Period-Cohort (APC) model was used to explore temporal trends, while the Bayesian Age-Period-Cohort (BAPC) model projected future PD burden from 2022 to 2030.

Results: From 1992 to 2021, global PD cases increased from 450,000 to 1.34 million, with crude incidence rates rising from 8.19 to 16.92 per 100,000 and ASIR from 11.54 to 15.63 per 100,000, indicating an annual net drift of 1.11% (95% CI 1.06%-1.17%), reflecting a growing burden driven by an aging population. All SDI regions saw a growth in PD burden, with the highest increases in middle- and high-middle-SDI regions, where male incidence was notably higher than female. Incidence rates escalated sharply in individuals aged 60 and older, peaking in those aged 85 and above. Projections suggest that by 2030, global PD cases will reach 1.93 million, with an ASIR of 27 per 100,000.

Discussion: The findings highlight a sustained global increase in PD burden, particularly in middle- and high-income regions and among men. In low-SDI areas, PD burden may be underestimated due to limited healthcare access and diagnostic challenges. These results stress the urgent need for health policies focused on elderly populations, especially men, and call for effective prevention and intervention strategies to mitigate the future impact of PD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
帕金森病发病率的全球趋势和预测:使用GBD 2021数据的30年分析
背景与目的:帕金森病(PD)是一种以多巴胺能神经元进行性丧失为特征的神经退行性疾病,可导致运动功能障碍和认知能力下降、抑郁等非运动症状。随着全球人口老龄化,PD发病率预计将上升,特别是在老年人口快速增长的地区。本研究利用全球疾病负担(GBD) 2021数据,按地区、性别和年龄组分析PD负担,检查1992年至2021年的趋势,并预测到2030年的未来负担。方法:分析GBD 2021数据库1992-2021年的数据,以评估不同社会人口指数(SDI)地区、性别和年龄组PD的年龄标准化发病率(ASIR)和死亡率。年龄-时期-队列(APC)模型用于探索时间趋势,而贝叶斯年龄-时期-队列(BAPC)模型预测了2022年至2030年的未来PD负担。结果:从1992年到2021年,全球PD病例从45万增加到134万,粗发病率从8.19 / 10万上升到16.92 / 10万,ASIR从11.54 / 10万上升到15.63 / 10万,年均净漂1.11% (95% CI 1.06%-1.17%),反映了人口老龄化带来的负担增加。所有SDI地区的PD负担都有所增加,其中中高SDI地区的PD负担增加最多,其中男性发病率明显高于女性。发病率在60岁及以上的人群中急剧上升,在85岁及以上的人群中达到顶峰。预测显示,到2030年,全球PD病例将达到193万例,ASIR为每10万人中有27例。讨论:研究结果强调全球PD负担持续增加,特别是在中高收入地区和男性中。在低sdi地区,由于有限的医疗保健和诊断挑战,PD负担可能被低估。这些结果强调迫切需要关注老年人群,特别是男性的卫生政策,并呼吁有效的预防和干预策略,以减轻PD的未来影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Neurology
Journal of Neurology 医学-临床神经学
CiteScore
10.00
自引率
5.00%
发文量
558
审稿时长
1 months
期刊介绍: The Journal of Neurology is an international peer-reviewed journal which provides a source for publishing original communications and reviews on clinical neurology covering the whole field. In addition, Letters to the Editors serve as a forum for clinical cases and the exchange of ideas which highlight important new findings. A section on Neurological progress serves to summarise the major findings in certain fields of neurology. Commentaries on new developments in clinical neuroscience, which may be commissioned or submitted, are published as editorials. Every neurologist interested in the current diagnosis and treatment of neurological disorders needs access to the information contained in this valuable journal.
期刊最新文献
Health-related quality of life in patients with vestibular schwannoma managed with observation, stereotactic radiosurgery or microsurgery: a systematic review and single-arm meta-analysis. Balance biomarker for early differentiation of Parkinson's disease and multiple system atrophy with parkinsonian type. Digital monitoring of disease activity in relapsing-remitting multiple sclerosis. Plasma p-tau217 assays effectively predict amyloid status but lack precision for tau staging in Alzheimer's disease. Symptoms of depression and anxiety are early predictors of multi-domain disability progression in progressive MS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1